Acorda Therapeutics, Inc. Gross Margin 2010-2024 | ACORQ
Current and historical gross margin for Acorda Therapeutics, Inc. (ACORQ) over the last 10 years. The current gross profit margin for Acorda Therapeutics, Inc. as of March 31, 2024 is %.
| Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-03-31 | $0.12B | $0.10B | 86.21% |
| 2023-12-31 | $0.12B | $0.10B | 86.44% |
| 2023-09-30 | $0.11B | $0.10B | 87.39% |
| 2023-06-30 | $0.12B | $0.10B | 82.05% |
| 2023-03-31 | $0.12B | $0.09B | 77.12% |
| 2022-12-31 | $0.12B | $0.09B | 74.79% |
| 2022-09-30 | $0.13B | $0.10B | 76.00% |
| 2022-06-30 | $0.12B | $0.09B | 73.77% |
| 2022-03-31 | $0.12B | $0.09B | 71.54% |
| 2021-12-31 | $0.13B | $0.09B | 68.22% |
| 2021-09-30 | $0.13B | $0.08B | 63.08% |
| 2021-06-30 | $0.15B | $0.11B | 69.08% |
| 2021-03-31 | $0.15B | $0.11B | 72.73% |
| 2020-12-31 | $0.15B | $0.12B | 77.78% |
| 2020-09-30 | $0.17B | $0.13B | 81.21% |
| 2020-06-30 | $0.16B | $0.13B | 83.13% |
| 2020-03-31 | $0.18B | $0.15B | 83.52% |
| 2019-12-31 | $0.19B | $0.16B | 82.29% |
| 2019-09-30 | $0.21B | $0.16B | 77.73% |
| 2019-06-30 | $0.31B | $0.24B | 79.08% |
| 2019-03-31 | $0.41B | $0.32B | 79.22% |
| 2018-12-31 | $0.47B | $0.38B | 79.62% |
| 2018-09-30 | $0.59B | $0.49B | 82.88% |
| 2018-06-30 | $0.59B | $0.48B | 81.97% |
| 2018-03-31 | $0.57B | $0.47B | 81.71% |
| 2017-12-31 | $0.59B | $0.48B | 81.26% |
| 2017-09-30 | $0.54B | $0.43B | 78.70% |
| 2017-06-30 | $0.54B | $0.42B | 78.88% |
| 2017-03-31 | $0.52B | $0.41B | 78.97% |
| 2016-12-31 | $0.52B | $0.41B | 79.23% |
| 2016-09-30 | $0.51B | $0.41B | 79.61% |
| 2016-06-30 | $0.52B | $0.42B | 80.65% |
| 2016-03-31 | $0.51B | $0.41B | 80.75% |
| 2015-12-31 | $0.49B | $0.40B | 80.93% |
| 2015-09-30 | $0.48B | $0.39B | 80.83% |
| 2015-06-30 | $0.44B | $0.35B | 79.91% |
| 2015-03-31 | $0.42B | $0.34B | 80.05% |
| 2014-12-31 | $0.40B | $0.32B | 79.85% |
| 2014-09-30 | $0.38B | $0.30B | 80.11% |
| 2014-06-30 | $0.36B | $0.29B | 80.06% |
| 2014-03-31 | $0.35B | $0.28B | 80.06% |
| 2013-12-31 | $0.34B | $0.27B | 80.12% |
| 2013-09-30 | $0.33B | $0.26B | 80.31% |
| 2013-06-30 | $0.32B | $0.26B | 80.76% |
| 2013-03-31 | $0.31B | $0.25B | 81.05% |
| 2012-12-31 | $0.31B | $0.25B | 81.64% |
| 2012-09-30 | $0.30B | $0.24B | 81.82% |
| 2012-06-30 | $0.31B | $0.24B | 77.96% |
| 2012-03-31 | $0.30B | $0.24B | 77.81% |
| 2011-12-31 | $0.29B | $0.23B | 77.05% |
| 2011-09-30 | $0.29B | $0.22B | 76.57% |
| 2011-06-30 | $0.26B | $0.21B | 80.54% |
| 2011-03-31 | $0.24B | $0.19B | 80.43% |
| 2010-12-31 | $0.19B | $0.16B | 80.73% |
| 2010-09-30 | $0.14B | $0.11B | 81.29% |
| 2010-06-30 | $0.09B | $0.07B | 82.22% |
| 2010-03-31 | $0.06B | $0.05B | 81.67% |
| 2009-12-31 | $0.05B | $0.04B | 81.48% |
